Advances in genomic medicine are playing an increasingly important role in the field of cardiology. Better analysis and understanding of patient genomic and epigenomic information can enable more personalised patient treatment and medical intervention. Here, Professor John Giannios considers the potential to use genomic medicine to prevent, monitor, diagnose and…
List view / Grid view
Coronary heart disease
A synthetically made glycopeptide biologic has shown promise as a treatment for obesity-related diseases in mice.